These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 26995367)

  • 1. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.
    Golwala H; Jackson LR; Simon DN; Piccini JP; Gersh B; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Thomas L; Fonarow GC; Peterson ED; Thomas KL;
    Am Heart J; 2016 Apr; 174():29-36. PubMed ID: 26995367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.
    Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE
    JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review.
    Ugowe FE; Jackson LR; Thomas KL
    Heart Rhythm; 2018 Sep; 15(9):1337-1345. PubMed ID: 29803022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study).
    Yong C; Azarbal F; Abnousi F; Heidenreich PA; Schmitt S; Fan J; Than CT; Ullal AJ; Yang F; Phibbs CS; Frayne SM; Ho PM; Shore S; Mahaffey KW; Turakhia MP
    Am J Cardiol; 2016 Jan; 117(1):61-8. PubMed ID: 26552504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
    O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
    Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
    JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation.
    Shen AY; Yao JF; Brar SS; Jorgensen MB; Wang X; Chen W
    Stroke; 2008 Oct; 39(10):2736-43. PubMed ID: 18635860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: An Analysis Using Administrative Claims Data.
    Kim MH; Xu L; Puckrein G
    Adv Ther; 2018 Nov; 35(11):2069-2080. PubMed ID: 30219991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry.
    An Y; Esato M; Ishii M; Iguchi M; Masunaga N; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Lip GYH; Akao M
    Heart Vessels; 2018 Dec; 33(12):1534-1546. PubMed ID: 29797059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Marinkovic JM; Lip GY
    Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.
    Kabra R; Cram P; Girotra S; Vaughan Sarrazin M
    Am J Cardiol; 2015 Jul; 116(2):230-5. PubMed ID: 26004053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Veterans Affairs Medical Center Racial and Ethnic Composition and Initiation of Anticoagulation for Atrial Fibrillation.
    Essien UR; Kim N; Hausmann LRM; Washington DL; Mor MK; Litam TMA; Boyer TL; Gellad WF; Fine MJ
    JAMA Netw Open; 2024 Jun; 7(6):e2418114. PubMed ID: 38913375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry(.).
    Ha AC; Singh N; Cox JL; Mancini GB; Dorian P; Fournier C; Gladstone DJ; Lockwood E; Shuaib A; Kajil M; Tsigoulis M; Gupta MK
    Can J Cardiol; 2016 Feb; 32(2):204-10. PubMed ID: 26195228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
    Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
    J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation.
    Shen AY; Chen W; Yao JF; Brar SS; Wang X; Go AS
    CNS Drugs; 2008; 22(10):815-25. PubMed ID: 18788834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
    Pokorney SD; Simon DN; Thomas L; Fonarow GC; Kowey PR; Chang P; Singer DE; Ansell J; Blanco RG; Gersh B; Mahaffey KW; Hylek EM; Go AS; Piccini JP; Peterson ED;
    Am Heart J; 2015 Jul; 170(1):141-8, 148.e1. PubMed ID: 26093875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry.
    Wutzler A; von Ulmenstein S; Attanasio P; Huemer M; Parwani AS; Boldt LH; Haverkamp W
    J Am Med Dir Assoc; 2015 Nov; 16(11):969-72. PubMed ID: 26123257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    O'Neal WT; Tanner RM; Efird JT; Baber U; Alonso A; Howard VJ; Howard G; Muntner P; Soliman EZ
    Int J Cardiol; 2015 Apr; 185():219-23. PubMed ID: 25797681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry].
    De Caterina R; Renda G; Sangiuolo R; Attena E; Di Lecce L; Romeo F;
    G Ital Cardiol (Rome); 2014 Feb; 15(2):99-109. PubMed ID: 24625849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.